Top Markets
#1 Status Status +21.05%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.55%
#3 Fake World Assets Fake World Assets +14.92%
#4 Ontology Gas Ontology Gas +12.78%
#5 GoPlus Security GoPlus Security +12.22%
#6 DMT-NAT DMT-NAT +8.79%
#7 Nillion Nillion +6.92%
#8 Provenance Blockchain Provenance Blockchain +6.68%
#9 Janction Janction +6.46%
#10 Bedrock Bedrock +5.82%
Coin of the day
Status Status
설정
언어
한국어
통화
USD
테마
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
주식 순위 #34063
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
주가
$0.223
마지막 동기화: 2026-08-14
시가총액
$6.32M
변동 (1일)
1.64%
변동 (1년)
-
국가
US
거래 Curanex Pharmaceuticals Inc Common Stock (CURX)

카테고리

Healthcare
Curanex Pharmaceuticals Inc Common Stock (CURX)의 주가 이력
최고 종가: $0.21 (2026-08-01 기준)

최저 종가: $4.87 (2025-08-01 기준)
Curanex Pharmaceuticals Inc Common Stock의 주가 이력 (2025 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 102.36%
2025 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE